المؤلفون: Hakkaart C; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Pearson JF; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Marquart L; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Public Health, University of Queensland, Brisbane, Australia., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Wiggins GAR; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Robinson BA; Department of Medicine, University of Otago, Christchurch, New Zealand.; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand., Mace PD; Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand., Aittomäki K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Azzollini J; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Balmaña J; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Barkardottir RB; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Belhadj S; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger L; Department of Clinical Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., Boonen SE; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Borde J; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Bradbury AR; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain., Buys SS; Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA., Caligo MA; SOD Genetica Molecolare, University Hospital, Pisa, Italy., Campbell I; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA., Claes KBM; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium., Collonge-Rame MA; Service de Génétique Biologique, CHRU de Besançon, Besançon, France., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK., Cosgrove C; Gynecologic Oncology, Translational Therapeutics, Department of Obstetrics and Gynecology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA., Dandiker S; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Davidson R; Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, UK., de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., de Putter R; Centre for Medical Genetics, Ghent University Hospital, Gent, Belgium., Delnatte C; Oncogénétique, Institut de Cancérologie de l'Ouest siteRené Gauducheau, Saint Herblain, France., Dhawan M; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA., Diez O; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital Campus, Barcelona, Spain.; Area of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Donaldson A; Clinical Genetics Department, St Michael's Hospital, Bristol, UK., Eason J; Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Ehrencrona H; Department of Clinical Genetics and Pathology, Laboratory Medicine, Skåne University Hospital, Lund, Sweden.; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany., Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Faust U; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany., Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain., Fostira F; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel., Frone M; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA., Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Gehrig A; Department of Human Genetics, University Würzburg, Würzburg, Germany., Gesta P; Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Hahnen E; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Hake CR; Waukesha Memorial Hospital-Pro Health Care, Waukesha, USA., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Hauke J; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Hentschel J; Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany., Herold N; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Honisch E; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Izquierdo A; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., James PA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Janavicius R; Faculty of Medicine, Institute of Biomedical Sciences, Dept. Of Human and Medical Genetics, Vilnius University, Vilnius, Lithuania.; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania., John EM; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Joseph V; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Kemp Z; Breast and Cancer Genetics Units, The Royal Marsden NHS Foundation Trust, London, UK., Kirk J; Familial Cancer Service, Weatmead Hospital, Wentworthville, New South Wales, Australia., Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Koudijs M; Department of Medical Genetics, University Medical Center, Utrecht, The Netherlands., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, China.; Department of Surgery, The University of Hong Kong, Hong Kong, China.; Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China., Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel., Lalloo F; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Lasset C; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France., Lautrup C; Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark., Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), ONCOBELL-IDIBELL-IGTP, CIBERONC, Barcelona, Spain., Legrand C; Département de Génétique, CHU de Grenoble, Grenoble, France., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Lesueur F; Genetic Epidemiology of Cancer team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., Mai PL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Mari V; Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Mebirouk N; Genetic Epidemiology of Cancer team, Inserm U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., Meindl A; Department of Gynecology and Obstetrics, University of Munich, Campus Großhadern, Munich, Germany., Miller A; NRG Oncology, Statistics and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Moserle L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Mouret-Fourme E; Service de Génétique, Institut Curie, Paris, France., Musgrave H; Department of Clinical Genetics, Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK., Nambot S; Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France., Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Yie JNY; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Cancer Genetics Service, National Cancer Centre, Singapore, Singapore., Nguyen-Dumont T; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia., Nikitina-Zake L; Latvian Biomedical Research and Study Centre, Riga, Latvia., Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA., Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) and Spanish Network on Rare Diseases (CIBERER), Madrid, Spain., Ott CE; Institute of Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pedersen IS; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Peixoto A; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal., Perez-Segura P; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Peterlongo P; Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy., Pocza T; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Ramser J; Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA., Rønlund K; Department of Clinical Genetics, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark., Rosenberg EH; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Schmutzler RK; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Shah PD; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Sharif S; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, UK., Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA., Side LE; Princess Anne Hospital, Southampton, UK., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada., Singer CF; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Snape K; Medical Genetics Unit, St George's, University of London, London, UK., Steinemann D; Institute of Human Genetics, Hannover Medical School, Hannover, Germany., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Cité, Paris, France., Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Tan YY; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal., Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Thull DL; Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA., Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Department of medicine, University Of Melbourne, Melbourne, Victoria, Australia., Tripathi V; South East Thames Regional Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., van Engelen K; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands., van Rensburg EJ; Department of Genetics, University of Pretoria, Arcadia, South Africa., Vega A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Viel A; Division of Functional onco-genomics and genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Walker L; Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK., Weitzel JN; Latin American School of Oncology, Tuxtla Gutiérrez, Chiapas, Mexico., Wevers MR; Radboud University Medical Center, Nijmegen, Netherlands., Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz.

مؤلفون مشاركون: GEMO Study Collaborators, EMBRACE Collaborators, SWE-BRCA Investigators, kConFab Investigators, HEBON Investigators

المصدر: Communications biology [Commun Biol] 2022 Oct 06; Vol. 5 (1), pp. 1061. Date of Electronic Publication: 2022 Oct 06.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; DNA Copy Number Variations ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; RNA, Messenger

المؤلفون: Buss LA; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand; Christchurch Heart Institute, Department of Medicine, University of Otago, Christchurch, New Zealand. Electronic address: linda.buss@otago.ac.nz., Williams T; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Hock B; Hematology Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Ang AD; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand; Present affiliation: Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Robinson BA; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand; Canterbury Regional Cancer and Hematology Service, Canterbury District Health Board, Christchurch, New Zealand., Currie MJ; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Dachs GU; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.

المصدر: Immunology letters [Immunol Lett] 2021 Nov; Vol. 239, pp. 60-71. Date of Electronic Publication: 2021 Sep 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0542 (Electronic) Linking ISSN: 01652478 NLM ISO Abbreviation: Immunol Lett Subsets: MEDLINE

مواضيع طبية MeSH: Exercise Therapy*, Breast Neoplasms/*therapy , Immune Checkpoint Inhibitors/*therapeutic use , Melanoma, Experimental/*therapy , Skin Neoplasms/*therapy, Animals ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Combined Modality Therapy/methods ; Drug Resistance, Neoplasm/immunology ; Female ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Melanoma, Experimental/immunology ; Melanoma, Experimental/pathology ; Mice ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; T-Lymphocytes, Cytotoxic/immunology ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology

المؤلفون: Crake RLI; Mackenzie Cancer Research Group, Christchurch, Department of Pathology and Biomedical Science, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8011, New Zealand. rebekah.crake@otago.ac.nz., Strother MR; Mackenzie Cancer Research Group, Christchurch, Department of Pathology and Biomedical Science, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8011, New Zealand.; Canterbury Regional Cancer and Haematology Services, Canterbury District Health Board, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand., Phillips E; Mackenzie Cancer Research Group, Christchurch, Department of Pathology and Biomedical Science, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8011, New Zealand., Doogue MP; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.; Canterbury Health Laboratories, Christchurch, New Zealand., Zhang M; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.; Canterbury Health Laboratories, Christchurch, New Zealand., Frampton CMA; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand., Robinson BA; Mackenzie Cancer Research Group, Christchurch, Department of Pathology and Biomedical Science, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8011, New Zealand.; Canterbury Regional Cancer and Haematology Services, Canterbury District Health Board, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand., Currie MJ; Mackenzie Cancer Research Group, Christchurch, Department of Pathology and Biomedical Science, University of Otago Christchurch, 2 Riccarton Avenue, PO Box 4345, Christchurch, 8011, New Zealand.

المصدر: Scientific reports [Sci Rep] 2021 Mar 11; Vol. 11 (1), pp. 5648. Date of Electronic Publication: 2021 Mar 11.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Breast Neoplasms/*blood , Breast Neoplasms/*drug therapy , Cytochrome P-450 Enzyme System/*metabolism , Cytokines/*blood , Inflammation Mediators/*blood, Antineoplastic Agents/pharmacology ; Feasibility Studies ; Female ; Humans

المؤلفون: Lattimore V; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. vanessa.lattimore@otago.ac.nz., Parsons MT; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Spurdle AB; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Pearson J; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Lehnert K; Centre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland, New Zealand., Sullivan J; Genetic Health Service NZ, South Island Hub, Christchurch Hospital, Christchurch, New Zealand., Lintott C; Genetic Health Service NZ, South Island Hub, Christchurch Hospital, Christchurch, New Zealand., Bawden S; Genetic Health Service NZ, South Island Hub, Christchurch Hospital, Christchurch, New Zealand., Morrin H; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.; Cancer Society Tissue Bank, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Robinson B; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand., Walker L; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Feb; Vol. 185 (3), pp. 583-590. Date of Electronic Publication: 2020 Oct 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics, BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Female ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Genetic Testing ; Germ-Line Mutation ; Heterozygote ; Humans ; New Zealand/epidemiology

المؤلفون: Mohamad Hanib MFB; Canterbury District Health Board, Christchurch Public Hospital, Christchurch, New Zealand., Robinson BA; Canterbury District Health Board, Christchurch Public Hospital, Christchurch, New Zealand., Frampton C; University of Otago, Christchurch, New Zealand., James ML; Canterbury District Health Board, Christchurch Public Hospital, Christchurch, New Zealand.

المصدر: Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2020 Dec; Vol. 64 (6), pp. 852-858. Date of Electronic Publication: 2020 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101469340 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-9485 (Electronic) Linking ISSN: 17549477 NLM ISO Abbreviation: J Med Imaging Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnostic imaging , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/surgery , Neoplasm Recurrence, Local*, Female ; Humans ; Mastectomy ; New Zealand ; Radiation Dose Hypofractionation

المؤلفون: Buss LA; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Ang AD; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Hock B; Hematology Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Robinson BA; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.; Canterbury Regional Cancer and Hematology Service, Canterbury District Health Board, Christchurch, New Zealand., Currie MJ; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Dachs GU; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.

المصدر: PloS one [PLoS One] 2020 Mar 18; Vol. 15 (3), pp. e0229290. Date of Electronic Publication: 2020 Mar 18 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*pathology , Melanoma, Experimental/*pathology , Physical Conditioning, Animal/*methods , Platelet Endothelial Cell Adhesion Molecule-1/*metabolism, Animals ; Breast Neoplasms/blood supply ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Female ; Humans ; Melanoma, Experimental/blood supply ; Melanoma, Experimental/metabolism ; Mice ; Mice, Inbred C57BL ; Neoplasm Transplantation ; Random Allocation ; Running ; Tumor Hypoxia ; Tumor Microenvironment

المؤلفون: Patel V; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, Radiation Oncology Department, Auckland City Hospital, Auckland, New Zealand. Electronic address: dr.vikash.patel.nz@gmail.com., James M; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand., Frampton C; University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand., Robinson B; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand., Davey V; Christchurch Breast Cancer Patient Register, Department of General Surgery, Christchurch, New Zealand., Timmings L; University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 369-376. Date of Electronic Publication: 2019 Oct 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Body Mass Index* , Mastectomy, Segmental* , Neoplasm Recurrence, Local*/mortality, Breast Neoplasms/*surgery, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Disease-Free Survival ; Female ; Humans ; Lymphatic Irradiation ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Grading ; New Zealand/epidemiology ; Obesity/epidemiology ; Overweight/epidemiology ; Prospective Studies ; Treatment Outcome ; Tumor Burden ; Young Adult

المؤلفون: Campbell EJ; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8011, New Zealand.; Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8140, New Zealand., Dachs GU; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8011, New Zealand., Morrin HR; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8011, New Zealand.; Cancer Society Tissue Bank, University of Otago, Christchurch, 8011, New Zealand., Davey VC; Christchurch Breast Cancer Patient Register, Christchurch Hospital, Christchurch, 8011, New Zealand., Robinson BA; Mackenzie Cancer Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8011, New Zealand.; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch, and Department of Medicine, University of Otago, Christchurch, 8011, New Zealand., Vissers MCM; Centre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago, Christchurch, 8140, New Zealand. margreet.vissers@otago.ac.nz.

المصدر: BMC cancer [BMC Cancer] 2019 Apr 03; Vol. 19 (1), pp. 307. Date of Electronic Publication: 2019 Apr 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer

مواضيع طبية MeSH: Antigens, Neoplasm/*metabolism , Ascorbic Acid/*metabolism , Breast Neoplasms/*pathology , Carbonic Anhydrase IX/*metabolism , Carcinoma, Ductal, Breast/*metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism , Membrane Proteins/*metabolism , Proto-Oncogene Proteins/*metabolism , Vascular Endothelial Growth Factor A/*metabolism, Antigens, Neoplasm/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Carbonic Anhydrase IX/genetics ; Cell Hypoxia ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Membrane Proteins/genetics ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Proto-Oncogene Proteins/genetics ; Retrospective Studies ; Survival Analysis ; Up-Regulation ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Lattimore VL; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. vanessa.lattimore@otago.ac.nz., Pearson JF; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. john.pearson@otago.ac.nz., Morley-Bunker AE; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. morar032@student.otago.ac.nz., Spurdle AB; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queenslan 4006, Australia. amanda.Spurdle@qimrberghofer.edu.au., Robinson BA; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. bridget.robinson@cdhb.health.nz.; Canterbury Regional Cancer and Haematology Service, Canterbury District Health Board, Christchurch Hospital, Christchurch 8011, New Zealand. bridget.robinson@cdhb.health.nz., Currie MJ; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. margaret.currie@otago.ac.nz., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand. logan.walker@otago.ac.nz.

مؤلفون مشاركون: kConFab Investigators; Research Department, Peter MacCallum Cancer Center, Melbourne 3010, Australia. heather.thorne@petermac.org.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 3010, Australia. heather.thorne@petermac.org.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2019 Feb 06; Vol. 20 (3). Date of Electronic Publication: 2019 Feb 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Alternative Splicing* , RNA, Messenger*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*genetics, Alleles ; Cell Line, Tumor ; Female ; Genotype ; Humans ; Single-Cell Analysis

المؤلفون: James M; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand.; University of Otago Christchurch, Christchurch Hospital, Christchurch, New Zealand., Swadi S; University of Otago Christchurch, Christchurch Hospital, Christchurch, New Zealand., Yi M; Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand., Johansson L; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand., Robinson B; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand.; University of Otago Christchurch, Christchurch Hospital, Christchurch, New Zealand., Dixit A; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand.

المصدر: Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2018 Jun; Vol. 62 (3), pp. 425-431. Date of Electronic Publication: 2018 Feb 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101469340 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1754-9485 (Electronic) Linking ISSN: 17549477 NLM ISO Abbreviation: J Med Imaging Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiation Dose Hypofractionation*, Breast Neoplasms/*radiotherapy , Myocardial Ischemia/*etiology, Breast Neoplasms/surgery ; Female ; Humans ; Incidence ; Mastectomy ; Middle Aged ; Myocardial Ischemia/epidemiology ; New Zealand/epidemiology ; Retrospective Studies ; Risk Factors ; Survival Rate ; Treatment Outcome